Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 1/20 | 0.63 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.58 |
| ▸ | THPO | P40225 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9149866 | 1.00 | TYR (0.63) | TYRCYP1A2NFKB1THPOALDH1A1 | |
| SCHEMBL154485 | 1.00 | TYR (0.63) | TYRCYP1A2NFKB1THPOALDH1A1 | |
| SCHEMBL4830684 | 1.00 | TYR (0.63) | TYRCYP1A2NFKB1THPOALDH1A1 | |
| SCHEMBL4277097 | 1.00 | TYR (0.63) | TYRCYP1A2NFKB1THPOALDH1A1 | |
| SCHEMBL3289586 | 1.00 | TYR (0.63) | TYRCYP1A2NFKB1THPOALDH1A1 | |
| SCHEMBL154484 | 1.00 | TYR (0.63) | TYRCYP1A2NFKB1THPOALDH1A1 | |
| SCHEMBL10814176 | 1.00 | TYR (0.63) | TYRCYP1A2NFKB1THPOALDH1A1 | |
| SCHEMBL344883 | 1.00 | TYR (0.63) | TYRCYP1A2NFKB1THPOALDH1A1 | |
| SCHEMBL3138148 | 1.00 | TYR (0.63) | TYRCYP1A2NFKB1THPOALDH1A1 | |
| SCHEMBL8439741 | 1.00 | TYR (0.63) | TYRCYP1A2NFKB1THPOALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1384 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180002683-A1 | ENGINEERED MULTIFUNCTIONAL ENZYMES AND METHODS OF USE | DANISCO US INC (US) | 2018-01-04 | — | — | US | claimed |
| US-20170362621-A1 | ENGINEERED MULTIFUNCTIONAL ENZYMES AND METHODS OF USE | DANISCO US INC (US) | 2017-12-21 | — | — | US | claimed |
| EP-3234119-A1 | ENGINEERED MULTIFUNCTIONAL ENZYMES AND METHODS OF USE | Danisco US Inc. (US) | 2017-10-25 | — | — | EP | claimed |
| EP-3234118-A1 | ENGINEERED MULTIFUNCTIONAL ENZYMES AND METHODS OF USE | Danisco US Inc. (US) | 2017-10-25 | — | — | EP | claimed |
| WO-2016100825-A1 | ENGINEERED MULTIFUNCTIONAL ENZYMES AND METHODS OF USE | DANISCO US INC (US) | 2016-06-23 | — | — | WO | claimed |
| WO-2016100837-A1 | ENGINEERED MULTIFUNCTIONAL ENZYMES AND METHODS OF USE | DANISCO US INC (US) | 2016-06-23 | — | — | WO | claimed |
| US-12624376-B2 | Mutants of a filamentous fungal cell having increased productivity in the production of a polypeptide | NOVOZYMES A/S (DK) | 2026-05-12 | — | — | US | disclosed |
| EP-3894551-B1 | POLYPEPTIDES HAVING XYLANASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME | NOVOZYMES AS (DK) | 2026-04-22 | — | — | EP | disclosed |
| US-12600996-B2 | Carbohydrate binding module variants and hybrid polypeptides comprising same | NOVOZYMES A/S (DK) | 2026-04-14 | — | — | US | disclosed |
| US-20260028649-A1 | YEAST EXPRESSING A HETEROLOGOUS PHOSPHOLIPASE FOR ETHANOL PRODUCTION | NOVOZYMES A/S (DK) | 2026-01-29 | — | — | US | disclosed |
| US-20250376702-A1 | ENZYME-EXPRESSING YEAST FOR ETHANOL PRODUCTION | NOVOZYMES A/S (DK) | 2025-12-11 | — | — | US | disclosed |
| EP-4638725-A1 | CARBOHYDRATE ESTERASE FAMILY 3 (CE3) POLYPEPTIDES HAVING ACETYL XYLAN ESTERASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME | Novozymes A/S (DK) | 2025-10-29 | — | — | EP | disclosed |
| EP-4638727-A1 | COMPOSITIONS COMPRISING ARABINOFURANOSIDASES AND A XYLANASE, AND USE THEREOF FOR INCREASING HEMICELLULOSIC FIBER SOLUBILIZATION | Novozymes A/S (DK) | 2025-10-29 | — | — | EP | disclosed |
| WO-1993025693-A1 | RECOMBINANT XYLANASES | THE AGRICULTURAL AND FOOD RESEARCH COUNCIL (GB) | 1993-12-23 | — | — | WO | disclosed |
| EP-0573536-A1 | XYLANASE, XYLANASE-PRODUCING BACILLUS AND APPLICATIONS THEREOF. | AGRONOMIQUE INST NAT RECH (FR) | 1993-12-15 | — | — | EP | disclosed |
| WO-1992013942-A1 | XYLANASE, XYLANASE-PRODUCING BACILLUS AND APPLICATIONS THEREOF | INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (INRA) (FR) | 1992-08-20 | — | — | WO | disclosed |
| WO-1992008466-A1 | HEPARAN SULFATE BIOSYNTHESIS PRIMERS | UAB RESEARCH FOUNDATION (US) | 1992-05-29 | — | — | WO | disclosed |
| US-5104856-A | Heparan sulfate biosynthesis primers | UAB RESEARCH FOUNDATION (US) | 1992-04-14 | — | — | US | disclosed |
| WO-1990001060-A1 | LOW MOLECULAR WEIGHT XYLANASE GLYCOPROTEIN | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 1990-02-08 | — | — | WO | disclosed |
| EP-0353342-A1 | Low molecular weight xylanase glycoprotein | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 1990-02-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12600996-B2 | Carbohydrate binding module variants and hybrid polypeptides comprising same | QPCTL, DNTT, RNGTT | TYR 4598/4885CYP1A2 4736/4885NFKB1 1078/4885 |
| US-12624376-B2 | Mutants of a filamentous fungal cell having increased productivity in the production of a polypeptide | CDC42, RAC1, RAC2 | TYR 1948/4885CYP1A2 3398/4885NFKB1 2953/4885 |
| US-20260028649-A1 | YEAST EXPRESSING A HETEROLOGOUS PHOSPHOLIPASE FOR ETHANOL PRODUCTION | AGL, RNGTT, PNP | TYR 1479/4885CYP1A2 2357/4885NFKB1 3442/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.